Rochester, NY 7/10/2009 10:34:10 PM
Morning Movers - RPRX - Repros Therapeutics Inc. Announces Amendment to NIH License Agreement
Repros Therapeutics Inc.,RPRX
Morning Movers - RPRX - Repros Therapeutics Inc. Announces Amendment to NIH License Agreement
---
Repros Therapeutics Inc.,RPRX
Last Trade: 4.33
Day's Range: 4.28 - 4.41
52wk Range: 4.20 - 13.94
Volume: 5,193
COMPANY "In The News"
Repros Therapeutics, Inc. today announced that it entered into the Sixth Amendment to its Agreement (the Agreement) with the National Institutes of Health (NIH) (the Amendment) relating to the Company’s lead product Proellex. The Amendment clarified that certain cancers related to the human reproductive system are within the scope of the licensed field, amended the development and commercialization benchmarks that the Company is required to meet under the Agreement and added or modified certain milestone payments due to NIH on the achievement of certain benchmarks.
COMPANY DETAILS
Repros Therapeutics Inc., a development stage biopharmaceutical company, focuses on the development of oral small molecule drugs for the treatment of male and female reproductive disorders. Its lead drug includes Proellex, a selective blocker of the progesterone receptor, which is in Phase III clinical trials for use as a pre-surgical treatment for women with anemia due to excessive menstrual bleeding associated with uterine fibroids, or anemia associated with uterine fibroids; in Phase III clinical trials for the chronic treatment of symptoms associated with uterine fibroids; and in Phase II clinical trials for the chronic treatment of symptoms associated with endometriosis.
---
At WhisperfromWallStreet.com we specialize in understand the markets, particularly the penny stock market and understand what makes penny stocks increase. In a word it is exposure and by that we mean making the investing public aware of a particular stock, via an investor awareness campaign. Our tracking is second to none with our alerts in 2009 producing an average price gain of 80%+. If you'd like to track our results or receive your own alerts based on our experience, sign up now at... WhisperfromWallStreet.com
---
It's important that every investor be aware of our disclaimer which can be read in its entirety :
http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
